Clinical chemistry and laboratory medicine最新文献

筛选
英文 中文
CD34+ progenitor cells meet metrology. CD34+ 祖细胞与计量学相遇。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-11-21 DOI: 10.1515/cclm-2024-1330
Bruno Brando, Arianna Gatti
{"title":"CD34+ progenitor cells meet metrology.","authors":"Bruno Brando, Arianna Gatti","doi":"10.1515/cclm-2024-1330","DOIUrl":"https://doi.org/10.1515/cclm-2024-1330","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expanded carrier screening for 224 monogenic disease genes in 1,499 Chinese couples: a single-center study. 对 1,499 对中国夫妇进行 224 个单基因疾病基因的扩大携带者筛查:一项单中心研究。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-11-20 DOI: 10.1515/cclm-2024-0649
Jianxin Tan, Juan Tan, Zhu Jiang, Binbin Shao, Yan Wang, Jingjing Zhang, Ping Hu, Chunyu Luo, Zhengfeng Xu
{"title":"Expanded carrier screening for 224 monogenic disease genes in 1,499 Chinese couples: a single-center study.","authors":"Jianxin Tan, Juan Tan, Zhu Jiang, Binbin Shao, Yan Wang, Jingjing Zhang, Ping Hu, Chunyu Luo, Zhengfeng Xu","doi":"10.1515/cclm-2024-0649","DOIUrl":"10.1515/cclm-2024-0649","url":null,"abstract":"<p><strong>Objectives: </strong>Expanded carrier screening (ECS) is a preventive genetic test that enables couples to know their risk of having a child affected by certain monogenetic diseases. This study aimed to evaluate the carrier frequency for rare monogenic diseases in the general Chinese population and the impacts of ECS on their reproductive decisions and pregnancy outcomes.</p><p><strong>Methods: </strong>This single-center study was conducted between September 2022 and April 2023. An ECS panel containing 224 recessive genes was offered to 1,499 Chinese couples from the general population who were at early gestational ages or planned to conceive.</p><p><strong>Results: </strong>Overall, 55.0 % of the individuals carried for at least one recessive condition. There were 16 autosomal recessive (AR) genes with a carrier frequency of ≥1/100 and 22 AR genes with a carrier frequency of <1/100 to ≥1/200. The most common AR and X-linked diseases were <i>GJB2</i>-related non-syndromic hearing loss, and hemolytic anemia, respectively. Fifty-five couples (3.67 %; 1 in 27.3) were at increased risk of having an affected child with 19 pregnant at the time of testing. Of these, 10 opted for amniocentesis, and four affected pregnancies were identified, with three of them being terminated.</p><p><strong>Conclusions: </strong>This study not only provides valuable information about the recessive genetic landscape, but also establishes a solid foundation for couple-based ECS in a real clinical setting.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Allowable total error in CD34 cell analysis by flow cytometry based on state of the art using Spanish EQAS data. 利用西班牙 EQAS 数据,根据最新技术,通过流式细胞仪分析 CD34 细胞的允许总误差。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-11-18 DOI: 10.1515/cclm-2024-0956
Sara Fernández-Luis, Alejandra Comins-Boo, Fernando Pérez-Pla, Juan Irure-Ventura, Andrés Insunza Gaminde, Marcos López-Hoyos, Lydia Blanco-Peris, M Carmen Martín Alonso, David San Segundo Arribas
{"title":"Allowable total error in CD34 cell analysis by flow cytometry based on state of the art using Spanish EQAS data.","authors":"Sara Fernández-Luis, Alejandra Comins-Boo, Fernando Pérez-Pla, Juan Irure-Ventura, Andrés Insunza Gaminde, Marcos López-Hoyos, Lydia Blanco-Peris, M Carmen Martín Alonso, David San Segundo Arribas","doi":"10.1515/cclm-2024-0956","DOIUrl":"10.1515/cclm-2024-0956","url":null,"abstract":"<p><strong>Objectives: </strong>CD34+ hematopoietic stem cell (HSC) enumeration, crucial for HSC transplantation, is performed by flow cytometry to guide clinical decisions. Variability in enumeration arises from biological factors, assay components, and technology. External quality assurance schemes (EQAS) train participants to minimize inter-laboratory variations. The goal is to estimate total error (TE) values for CD34 cell enumeration using state-of-the-art (SOTA) methods with EQA data and to define quality specifications by comparing TE using different cutoffs.</p><p><strong>Methods: </strong>A total of 3,994 results from 40 laboratories were collected over 11 years (2011-2022) as part of the IC-2 Stem Cells Scheme of the GECLID Program that includes absolute numbers of CD34 cells. The data were analyzed in two periods: 2011-2016 and 2017-2022. The TE value achieved by at least 60 %, 70 %, 80 %, and 90  % of laboratories was calculated across the two different periods and at various levels of CD34 cell counts: above 25, 25 to 15, and under 15 cells/μL.</p><p><strong>Results: </strong>A decrease in the SOTA-based TE for CD34 cell enumeration was observed in the most recent period in 2017-2021 compared with 2012-2016. A significant increase of P75 TE values in the low CD34 range (<15 cells/μL) levels was found (p<0.001).</p><p><strong>Conclusions: </strong>Technical advancements contribute to the decrease TE over time. The TE of CD34 cell FC counts is measure-dependent, making it responsive to precision enhancement strategies. The TE measured by EQAS in this study may serve as a quality specification for implementing ISO 15189 standards in clinical laboratories for CD34 cell enumeration.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142616107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of capillary finger stick and venous blood sampling for 34 routine chemistry analytes: potential for in the hospital and remote blood sampling. 毛细管指签采血与静脉采血检测 34 种常规化学分析物的比较:医院内和远程血液采样的潜力。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-11-18 DOI: 10.1515/cclm-2024-0812
Martijn J H Doeleman, Anne-Fleur Koster, Anouk Esseveld, Hans Kemperman, Joost F Swart, Sytze de Roock, Wouter M Tiel Groenestege
{"title":"Comparison of capillary finger stick and venous blood sampling for 34 routine chemistry analytes: potential for in the hospital and remote blood sampling.","authors":"Martijn J H Doeleman, Anne-Fleur Koster, Anouk Esseveld, Hans Kemperman, Joost F Swart, Sytze de Roock, Wouter M Tiel Groenestege","doi":"10.1515/cclm-2024-0812","DOIUrl":"https://doi.org/10.1515/cclm-2024-0812","url":null,"abstract":"<p><strong>Objectives: </strong>This study examined the comparability of venous and capillary blood samples with regard to routine chemistry analytes.</p><p><strong>Methods: </strong>Venous and capillary blood samples were collected from adult patients to assess comparability of alanine transaminase, albumin, alkaline phosphatase, apolipoprotein B, aspartate aminotransferase, total bilirubin, calcium, chloride, creatin kinase, creatinine, C-reactive protein, ferritin, folic acid, free T4, gamma glutamyltransferase, glucose, high density lipoprotein cholesterol, iron, lipase, lipoprotein a, magnesium, phosphate, postassium, prostate specific antigen, sodium, total cholesterol, total protein, transferrin, triglycerides, thyroid stimulating hormone, urate, urea, vitamin B12 and 25-hydroxyvitamin-D3. Furthermore, hemolysis-icterus-lipemia Index (HIL-Index) was measured for all samples. All measurements were performed using the Siemens Atellica<sup>®</sup> CH or IH Analyzer. Deming regression analysis and mean relative differences between venous and capillary measurements of each analyte were contrasted with the desirable total allowable error (TEa) and Clinical Laboratory Improvement Amendments (CLIA) 2024 proposed acceptance limits for proficiency testing.</p><p><strong>Results: </strong>Deming regression and mean relative differences demonstrated excellent comparability between venous and capillary samples for most measured analytes.</p><p><strong>Conclusions: </strong>Capillary and venous samples showed comparable results for almost all studied chemistry analytes. Of the 33 studied analytes for which TEa criteria where available, 30 met TEa criteria. CLIA 2024 criteria where available for 29 of the studied analytes of which only glucose did not meet the criteria. In conclusion, capillary blood draw is a suitable alternative for venous blood sampling for measuring most of the investigated analytes. This benefits patients with fear of needles and might pave the way for remote self-sampling.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The first case of Teclistamab interference with serum electrophoresis and immunofixation. 首例特克司他单抗干扰血清电泳和免疫固定的病例。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-11-13 DOI: 10.1515/cclm-2024-1125
Kamran Kadkhoda, Beth Faiman, Jason Valent, Samer Albahra, Nicole Boyert
{"title":"The first case of Teclistamab interference with serum electrophoresis and immunofixation.","authors":"Kamran Kadkhoda, Beth Faiman, Jason Valent, Samer Albahra, Nicole Boyert","doi":"10.1515/cclm-2024-1125","DOIUrl":"https://doi.org/10.1515/cclm-2024-1125","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142616130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic performances and cut-off verification of blood pTau 217 on the Lumipulse platform for amyloid deposition in Alzheimer's disease. Lumipulse 平台上血液 pTau 217 对阿尔茨海默病淀粉样沉积的诊断性能和临界验证。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-11-13 DOI: 10.1515/cclm-2024-1091
Giulia Musso, Carlo Gabelli, Annachiara Cagnin, Chiara Cosma, Diego Cecchin, Giovanni Zorzi, Martina Zaninotto, Valentina Misenti, Angelo Antonini, Mario Plebani, Daniela Basso
{"title":"Diagnostic performances and cut-off verification of blood pTau 217 on the Lumipulse platform for amyloid deposition in Alzheimer's disease.","authors":"Giulia Musso, Carlo Gabelli, Annachiara Cagnin, Chiara Cosma, Diego Cecchin, Giovanni Zorzi, Martina Zaninotto, Valentina Misenti, Angelo Antonini, Mario Plebani, Daniela Basso","doi":"10.1515/cclm-2024-1091","DOIUrl":"https://doi.org/10.1515/cclm-2024-1091","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142616108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reviewer Acknowledgment. 审稿人致谢。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-11-13 DOI: 10.1515/cclm-2024-2001
{"title":"Reviewer Acknowledgment.","authors":"","doi":"10.1515/cclm-2024-2001","DOIUrl":"https://doi.org/10.1515/cclm-2024-2001","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142616128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Performance evaluation of the introduction of full sample traceability system within the specimen collection process. 在样本采集过程中引入全样本可追溯系统的性能评估。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-11-12 DOI: 10.1515/cclm-2024-0854
Emanuela Foglia, Elisabetta Garagiola, Lucrezia Ferrario, Mario Plebani
{"title":"Performance evaluation of the introduction of full sample traceability system within the specimen collection process.","authors":"Emanuela Foglia, Elisabetta Garagiola, Lucrezia Ferrario, Mario Plebani","doi":"10.1515/cclm-2024-0854","DOIUrl":"https://doi.org/10.1515/cclm-2024-0854","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the efficacy, safety and efficiency performances related to the introduction of innovative traceability platforms and integrated blood collection systems, for the improvement of a total testing process, thus also assessing the economic and organizational sustainability of these innovative technologies.</p><p><strong>Methods: </strong>A mixed-method approach was utilized. A key-performance indicators dashboard was created based on a narrative literature review and expert consensus and was assessed through a real-life data collection from the University Hospital of Padova, Italy, comparing three scenarios over time (2013, 2016, 2019) with varying levels of technological integration. The economic and organizational sustainability was determined considering all the activities performed from the tube check-in to the validation of the results, with the integration of the management of the prevalent errors occurred during the process.</p><p><strong>Results: </strong>The introduction of integrated venous blood collection and full sample traceability systems resulted in significant improvements in laboratory performance. Errors in samples collected in inappropriate tubes decreased by 42 %, mislabelled samples by 47 %, and samples with irregularities by 100 %. Economic analysis revealed a cost saving of 12.7 % per tube, equating to a total saving of 447,263.80 € over a 12-month period. Organizational efficiency improved with a reduction of 13,061.95 h in time spent on sample management, allowing for increased laboratory capacity and throughput.</p><p><strong>Conclusions: </strong>Results revealed the strategic relevance of introducing integrated venous blood collection and full sample traceability systems, within the Laboratory setting, with a real-life demonstration of TLA economic and organizational sustainability, generating an overall improvement of the process efficiency.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142616110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigation between EQA and sustainability. EQA 与可持续性之间的导航。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-11-12 DOI: 10.1515/cclm-2024-1240
Tony Badrick, Zoe Vayanos, John Sioufi
{"title":"Navigation between EQA and sustainability.","authors":"Tony Badrick, Zoe Vayanos, John Sioufi","doi":"10.1515/cclm-2024-1240","DOIUrl":"https://doi.org/10.1515/cclm-2024-1240","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142616109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How has the external quality assessment/proficiency testing of semen analysis been developed in the past 34 years: a review. 精液分析的外部质量评估/能力测试在过去 34 年中是如何发展的:综述。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-11-08 DOI: 10.1515/cclm-2024-1062
Yan Zheng, Yingbi Wu, Lin Yu, Yelin Jia, Tingting Yang, Qingyuan Cheng, Jiao Qin, Xiao Liu, Min Jiang, Fuping Li
{"title":"How has the external quality assessment/proficiency testing of semen analysis been developed in the past 34 years: a review.","authors":"Yan Zheng, Yingbi Wu, Lin Yu, Yelin Jia, Tingting Yang, Qingyuan Cheng, Jiao Qin, Xiao Liu, Min Jiang, Fuping Li","doi":"10.1515/cclm-2024-1062","DOIUrl":"https://doi.org/10.1515/cclm-2024-1062","url":null,"abstract":"<p><p>Male infertility has become an important issue of global concern. Semen analysis is the cornerstone of male fertility assessment. External quality assessment (EQA) of sperm concentration, motility, and morphology is widely recognized in the world. However, over the past 34 years, the implementation of EQA for semen analysis has varied across different countries, and there is no global consensus. The goal of this paper is to first explore the overall development of EQA during this period. Secondly, it aims to discuss the extent of difference of participating laboratories in different countries. Finally, the paper examines the differences in EQA programs developed by various EQA providers in order to seek a global standard. In total, 29 papers met the inclusion criteria and were included in this review. There is inconsistent in the implementation of EQA across different countries, and there is no global consensus. Policies for EQA of semen analysis vary from country to country. Some countries mandate laboratory participation, while others permit voluntary involvement. Different EQA organizers choose different ways to calculate assigned value and acceptance limits. The coefficient of variation (CV) for each EQA item was large. The CVs of concentration, motility, morphology, and viability were 12.7-138.0 %, 17.0-127.0 %, 7-375 %, and 6-41.1 %, respectively. The results of the semen analysis varied considerably among the participating laboratories. The collaborative efforts of national policymakers, EQA organizers, and all participating laboratories are essential to improving the current situation.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142603555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信